THOMAS C FREYMAN Insider Trading $AGN Allergan plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THOMAS C FREYMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THOMAS C FREYMAN. THOMAS C FREYMAN is Executive Vice President in ABBOTT LABORATORIES ($ABT) and Senior Vice President in ABBOTT LABORATORIES ($ABT) and Director in HANGER, INC. ($HGR) and Director in TENNECO INC ($TEN) and Director in AbbVie Inc. ($ABBV) and Director in Allergan plc ($AGN).
THOMAS C FREYMAN in Allergan plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of THOMAS C FREYMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 11 2020
$AGN Market Capitalization: $87.25B
$AGN Previous Close: $234.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of THOMAS C FREYMAN in Allergan plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, ABBV, AGN, HGR, TEN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2020 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Sell | D | 0.00 | 2,983 | 0 | 0 | 3 K to 0 (-100.00 %) |
| May 11 2020 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Sell | D | 0.00 | 2,983 | 0 | 0 | 3 K to 0 (-100.00 %) |
| May 04 2020 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Payment of Exercise | F | 189.74 | 2,064 | 391,623 | 2,983 | 5 K to 3 K (-40.90 %) |
| May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Grant | A | 145.33 | 2,064 | 299,961 | 3,974 | 1.9 K to 4 K (+108.06 %) |
| May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Payment of Exercise | F | 147.00 | 748 | 109,956 | 1,910 | 2.7 K to 1.9 K (-28.14 %) |
| May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Grant | A | 145.33 | 2,064 | 299,961 | 3,974 | 1.9 K to 4 K (+108.06 %) |
| May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Payment of Exercise | F | 147.00 | 748 | 109,956 | 1,910 | 2.7 K to 1.9 K (-28.14 %) |
| Sep 04 2018 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Buy | P | 190.69 | 1,100 | 209,759 | 2,658 | 1.6 K to 2.7 K (+70.60 %) |
| Jun 15 2018 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Grant | A | 170.23 | 1,558 | 265,218 | 1,558 | 0 to 1.6 K |
Page: 1